HomeOwner SearchCategory Search
Visit USCODrug Delivery and Translational Research [Published: 2019-07-09. Issue: vol. 9, no. 4, August 2019]
Serial Registration
Copyright Title
Drug Delivery and Translational Research [Published: 2019-07-09. Issue: vol. 9, no. 4, August 2019]
Status
Published
on 28 Aug 2019
Year of Creation
2019
Copyright Claimant
Controlled Release Society
Registration Number
TX0008793075
on 28 Aug 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008793075) dated 28 Aug 2019, pertains to an electronic file (eService) titled "Drug Delivery and Translational Research [Published: 2019-07-09. Issue: vol. 9, no. 4, August 2019]" created in 2019. The copyright holder is Controlled Release Society, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Controlled Release Society.
Application Details
Registration Number
TX0008793075
Registration Date
8/28/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Controlled Release Society
First Publication Nation
United States
ISSN
2190-393X
Preexisting Material
text
Notes
Copyright Local Holdings: vol. 9, no. 4, August 2019 Created 2019 Pub. 2019-07-09 Reg. 2019-08-28 TX0008793075 KADA
Material Matter Claimed Note: compilation
Statements
Application Title Statement: Drug Delivery and Translational Research
Author Statement: Controlled Release Society employer for hire Domicile: United States Citizenship: United States Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.